HBV polymerase (reverse transcriptase)

Assets acting on this target.

Class
Nucleoside analogue HBV polymerase inhibitor

By indication

Related mechanisms

HBV polymerase (reverse transcriptase) drugs compared

6 drugs, stage by indication
6 drugs acting on HBV polymerase (reverse transcriptase): developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Entecavir (Baraclude)BaracludeBristol-Myers Squibbsmall moleculeApprovedApproved in Chronic Hepatitis B
lamivudine (Epivir-HBV)Epivir-HBVGlaxoSmithKlinesmall moleculeApprovedApproved in Chronic Hepatitis B
tenofovir alafenamide (Vemlidy)VemlidyGilead Sciencessmall moleculeApprovedApproved in Chronic Hepatitis B
Besifovir dipivoxil (Besivo)IlDong Pharmaceutical Co., Ltd., LG Chemsmall moleculePhase 3Phase 3 in Chronic Hepatitis B
Tenofovir amibufenamide (Hengmu)HengmuHansoh Pharmaceutical Groupsmall moleculePhase 3Phase 3 in Chronic Hepatitis B
Entecavir (Cavir)Hanmi Pharmaceuticalsmall moleculePhase 1Not recorded

← all mechanisms